Dianthus Therapeutics posts updated corporate presentation; no specific material changes disclosed

Dianthus Therapeutics, Inc. /DE/

Updated corporate presentation posted on company's investor relations website on November 3, 2025.
Presentation filed as Exhibit 99.1 to the 8-K; detailed content not available in the excerpt provided.
No financial results, pipeline updates, or guidance changes are included in the filing text.
Routine update; no material new operational or strategic information identified.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.